tirzepatide mounjaro for weight loss New Trial Results Position FDA Drug Approval What's better for weight loss,

Now I want to hear from you: Are you someone who has taken or is currently taking a GLP-1 agonist

Solomon SD, Ostrominski JW, Wang X, Shah SJ, Borlaug BA, Butler J, et al

When digested, food is broken into more simple components

2023: The FDA approved tirzepatide as Zepbound for the treatment for chronic weight management in adults with an initial body mass index (BMI) of: 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, dyslipidemia, type 2 diabetes mellitus, obstructive sleep apnea or cardiovascular disease)

This hormone does a few things: It triggers insulin release from your pancreas, which in turn helps to better regulate your blood sugar